Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose montelukast versus placebo for exercise-induced bronchoconstriction in children
2007-004879-19Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of montelukast in exercise-induced bronchospasm (EIB) and asthma (2 arms), sponsored by Merck & Co. Primary endpoints: Maximum percent fall from pre-exercise baseline in FEV1, AUC0-60 min for FEV1 response and 2 more. Started Nov 2007; status: completed.
02
Drugs
montelukast
03
Conditions
exercise-induced bronchospasm (EIB)asthma
Beyond the preview
Go deeper on 2007-004879-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004879-19.